Using Mental Imagination to Prevent Excessive Gestational Weight Gain in Overweight and Obese Pregnant Women (MAWI)

November 14, 2024 updated by: Mei-Wei Chang, Ohio State University
Moms Are Worth It is a lifestyle behavior intervention study aims to prevent excessive gestational weight gain in overweight or obese pregnant women through promotion of the stress management, healthy eating, and physical activity. Eligible women will be randomly assigned to a usual care or an intervention plus usual care group. The intervention will last 20 weeks and will be delivered via weekly web and individual health coaching session (10 of them)

Study Overview

Status

Completed

Detailed Description

Current effective lifestyle behavior intervention studies aimed to prevent excessive gestational weight gain (EGWG) in overweight or obese pregnant women have limited practicality, scalability, and sustainability because of high participant burden and excessive cost for clinical practice. Also, prior studies paid little or no attention to motivation, emotion and cognition, all of which are critical to motivate and enable individuals to engage in healthy lifestyle behaviors and achieve positive health outcomes. A promising approach to prevent EGWG in overweight or obese pregnant women is through goal-oriented episodic future thinking (GOEFT). This pilot randomized controlled trial, aims to prevent EGWG in overweight or obese pregnant women. The proposed self-directed, web-based GOEFT intervention will focus on increasing motivation (autonomous motivation and self-efficacy) and improving emotion (emotion control and stress) and cognition (executive function, ExF), thus promoting healthy lifestyle behaviors. This will lead to prevention of EGWG and a reduced rate of gestational diabetes, gestational hypertension, cesarean delivery and fetal macrosomia. Our intervention will last 20 weeks (starting at 17 week-gestation). Participants (N = 90; 50% White, 50% minority) will be recruited and enrolled from prenatal care clinics at The Ohio State University Wexner Medical Center and be randomly assigned to our GOEFT intervention (n = 45) or usual care (n = 45). All participants will be assessed at baseline (<17 week-gestation, T1), 24-27 week-gestation (T2) and 35-37 week-gestation (T3). Specific aims are (1) to determine feasibility of the GOEFT intervention: recruitment, randomization, retention and intervention implementation, (2) to investigate the potential efficacy of the intervention on gestational weight gain and maternal and birth outcomes, (3) to investigate the potential impact of the intervention on lifestyle behaviors and (4) to investigate the potential impact of the intervention on motivation, emotion and cognition.

Study Type

Interventional

Enrollment (Actual)

70

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ohio
      • Columbus, Ohio, United States, 43210
        • The Ohio State University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Participants must be pregnant women ≤ 13 week-gestation with a single fetus as assessed by ultrasound.
  • Participants must also have self-reported pre-pregnancy body mass index (BMI) of 25.0-45.0 kg/m2 and height (height and weight to compute body mass index).
  • Ability to read and speak English,
  • Age of 18-45 years,
  • Access to a working smart phone with unlimited text messaging,
  • Access to internet,
  • Receipt of prenatal care from our collaborating clinics and plan to deliver the baby at The Ohio State University (OSU) Wexner Medical Center,
  • Resident of Franklin Count,
  • Committed to the 20-week intervention.

Exclusion Criteria:

  • Self-reported history of ≥ 3 miscarriages,
  • Planned termination of the pregnancy,
  • Diagnosed hypertension and/or type 1 or 2 diabetes,
  • History of or current diagnosis of an eating disorder,
  • Serious current physical disease (e.g., renal disease or cancer),
  • Past bariatric surgery,
  • Current or history of substance abuse in the past 6 months,
  • Current treatment for a serious psychological disorder (e.g., schizophrenia and bipolar disorder),
  • Contraindications to walking,
  • Consented women will become not eligible to participate in the study if they are not randomized by 16-week 6 days gestation. This is because the study intervention starts ≤ 17 weeks gestation.
  • Women will become not ineligible for participation if they did not complete the baseline data.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Goal-Oriented Episodic Future Thinking (GOEFT) Intervention
In addition to usual prenatal care, intervention participants will receive a 20-week intervention via web and individual health counseling. The intervention topics focus on stress management, healthy eating, and physical activity.
Individuals in the intervention group will receive a 20-week web-based intervention and individual health coaching focused on stress management, healthy eating and physical activity.
No Intervention: Usual Prenatal Care
The usual prenatal care group will receive usual care from their providers

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percent Change in Body Weight
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
Data extracted from electronic medical record
Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
Percent Change in Body Weight
Time Frame: 24-27 week-gestation (T2) to 35-37 week-gestation (T3)
Data extracted from electronic medical record
24-27 week-gestation (T2) to 35-37 week-gestation (T3)
Percent Change in Body Weight
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
Data extracted from electronic medical record
Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Autonomous Motivation for Stress Management
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)

Will be measured using Treatment Self-Regulation Questionnaire (6 items) to measure autonomous motivation for stress management (6 items)

Values are: 1 - Not At All True, 2, 3, 4 - Somewhat True, 5, 6, 7 - Very True

The investigators will sum 6 items to create a composite score, ranging from 6 to 42.

Higher scores indicate higher autonomous motivation for stress management.

Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
Change in Autonomous Motivation for Healthy Eating
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)

Will be measured using Treatment Self-Regulation Questionnaire (6 items) to measure autonomous motivation for Healthy Eating (6 items)

Values are: 1 - Not At All True, 2, 3, 4 - Somewhat True, 5, 6, 7 - Very True

The investigators will sum 6 items to create a composite score, ranging from 6 to 42.

Higher scores indicate higher autonomous motivation for Healthy Eating.

Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
Change in Autonomous Motivation for Physical Activity
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)

Will be measured using Treatment Self-Regulation Questionnaire (6 items) to measure autonomous motivation for Physical Activity (6 items)

Values are: 1 - Not At All True, 2, 3, 4 - Somewhat True, 5, 6, 7 - Very True

The investigators will sum 6 items to create a composite score, ranging from 6 to 42.

Higher scores indicate higher autonomous motivation for Physical Activity.

Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
Change in Autonomous Motivation for Stress Management
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)

Will be measured using Treatment Self-Regulation Questionnaire (6 items) to measure autonomous motivation for stress management (6 items)

Values are: 1 - Not At AllTrue, 2, 3, 4 - Somewhat True, 5, 6, 7 - Very True

The investigators will sum 6 items to create a composite score, ranging from 6 to 42.

Higher scores indicate higher autonomous motivation for stress managment.

Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
Change in Autonomous Motivation for Healthy Eating
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)

Will be measured using Treatment Self-Regulation Questionnaire (6 items) to measure autonomous motivation for Healthy Eating (6 items)

Values are: 1 - Not At All True, 2, 3, 4 - Somewhat True, 5, 6, 7 - Very True

The investigators will sum 6 items to create a composite score, ranging from 6 to 42.

Higher scores indicate higher autonomous motivation for Healthy Eating

Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
Change in Autonomous Motivation for Physical Activity
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)

Will be measured using Treatment Self-Regulation Questionnaire (6 items) to measure autonomous motivation for Physical Activity (6 items)

Values are: 1 - Not At All True, 2, 3, 4 - Somewhat True, 5, 6, 7 - Very True

The investigators will sum 6 items to create a composite score, ranging from 6 to 42.

Higher scores indicate higher autonomous motivation for Physical Activity.

Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
Change in Coping Self-efficacy
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)

Will be measured using a "Survey for Coping Self-efficacy" (10 items)

Values are: 1 - Not At All Confident, 2 - Not Too Confident, 3 - Somewhat Confident, 4 - Very Confident

The investigators will sum 10 items to create a composite score, ranging from 10 to 40.

Higher scores indicate higher coping self-efficacy.

Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
Change in Coping Self-efficacy
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)

Will be measured using a "Survey for Coping Self-efficacy" (10 items)

Values are: 1 - Not At All Confident, 2 - Not Too Confident, 3 - Somewhat Confident, 4 - Very Confident

The investigators will sum 10 items to create a composite score, ranging from 10 to 40.

Higher scores indicate higher coping self-efficacy.

Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
Change in Healthy Eating Self-efficacy
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)

Will be measured using a "Survey for Healthy Eating Self-efficacy" (8 items)

Values are: 1 - Not At All Confident, 2 - Not Too Confident, 3 - Somewhat Confident, 4 - Very Confident.

The investigators will sum all 8 items to create a composite score, ranging from 8 to 32.

The higher score, the higher healthy eating self-efficacy.

Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
Change in Healthy Eating Self-efficacy
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)

Will be measured using a "Survey for Healthy Eating Self-efficacy" (8 items)

Values are: 1 - Not At All Confident, 2 - Not Too Confident, 3 - Somewhat Confident, 4 - Very Confident

The investigators will sum all 8 items to create a composite score, ranging from 8 to 32. The higher score, the higher healthy eating self-efficacy.

Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
Change in Physical Activity Self-efficacy
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)

Will be measured using a "Survey for Physical Activity Self-efficacy" (10 items) that ask participants' confidence in performing the specific activity.

Values are: 1 - Not At All Confident, 2 - Not Too Confident, 3 - Somewhat Confident, 4 - Very Confident

The investigators will sum all 10 items to create a composite score, ranging from 10 to 40. The higher score, the higher physical activity self-efficacy.

Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
Change in Physical Activity Self-efficacy
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)

Will be measured using a "Survey for Physical Activity Self-efficacy" (10 items) that ask participants' confidence in performing the specific activity.

Values are: 1 - Not At All Confident, 2 - Not Too Confident, 3 - Somewhat Confident, 4 - Very Confident

The investigators will sum all 10 items to create a composite score, ranging from 10 to 40. The higher score, the higher physical activity self-efficacy.

Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
Change in Perceived Stress
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)

Will be measured using The Perceived Stress Scale (10 items) that measures the degree to which situations in one's life are appraised as stressful.

Values are: 0 - Never, 1 - Almost Never, 2 - Sometimes, 3 - Fairly Often, 4 - Very Often

The investigators will sum 10 items to create a composite score, ranging from 0 to 40.

The higher score, the higher levels of perceived stress.

Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
Change in Perceived Stress
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)

Will be measured using The Perceived Stress Scale (10 items) that measures the degree to which situations in one's life are appraised as stressful.

Values are: 0 - Never, 1 - Almost Never, 2 - Sometimes, 3 - Fairly Often, 4 - Very Often

The investigators will sum 10 items to create a composite score, ranging from 0 to 40.

The higher score, the higher levels of perceived stress.

Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
Percentage of Participants Diagnosed With Gestational Diabetes
Time Frame: 24-27 week-gestation (T2) to 35-37 week-gestation (T3)
Data extracted from electronic medical record. Percentage of participants who were diagnosed with Gestational Diabetes during the study timeframe.
24-27 week-gestation (T2) to 35-37 week-gestation (T3)
Percentage of Participants Diagnosed With Gestational Hypertension
Time Frame: 24-27 week-gestation (T2) to 35-37 week-gestation (T3)
Data extracted from electronic medical record. Percentage of participants diagnosed with Gestational Hypertension in the study timeframe.
24-27 week-gestation (T2) to 35-37 week-gestation (T3)
Percentage of Participants With Cesarean Delivery
Time Frame: 35-37 week-gestation (T3)
Data extracted from electronic medical record. Percentage of participants who experienced Cesarean Delivery.
35-37 week-gestation (T3)
Newborn Body Weight
Time Frame: 35-37 week-gestation (T3)
Data extracted from electronic medical record. Newborn Body Weight taken at birth.
35-37 week-gestation (T3)
Percentage of Participants With Premature (<37 Weeks Gestation) Births
Time Frame: 35-37 week-gestation (T3)
Gestational age for each participant was extracted from electronic medical record and births before 37 weeks gestation were considered to be premature. The number of premature births was averaged within the study groups.
35-37 week-gestation (T3)
Percentage of Change in Dietary Intake Behaviors - Caloric Intake (Kcal)
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)

Assessed using the National Cancer Institute Automated Self-Administered 24-hour Recall (ASA24). Participants completed 24-hour Dietary Recalls on two random days over a week. The variable of interest - calories (Kcal) - values for the 2 24-hour periods were added to ascertain the total amount consumed at the specific data collection time periods.

Data from Baseline (T1) was compared to that collected at T2 for each participant and averaged for an aggregate score. Positive numbers represent an increase in calories consumed, negative numbers represent a decrease in calories consumed.

Only participants who completed 2 days worth of dietary data were included in this analysis.

Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
Percentage of Change in Dietary Intake Behaviors - Fat (gm)
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)

Assessed using the National Cancer Institute Automated Self-Administered 24-hour Recall (ASA24). Participants completed 24-hour Dietary Recalls on two random days over a week. The variable of interest - fat (gm) - values for the 2 24-hour periods were added to ascertain the total amount consumed at the specific data collection time periods.

Data from Baseline (T1) was compared to that collected at T2 for each participant and averaged for an aggregate score. Positive numbers represent an increase in fat consumed, negative numbers represent a decrease in fat consumed.

Only participants who completed 2 days worth of dietary data were included in this analysis.

Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
Percentage of Change in Dietary Intake Behaviors - Fruit (Cup)
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)

Assessed using the National Cancer Institute Automated Self-Administered 24-hour Recall (ASA24). Participants completed 24-hour Dietary Recalls on two random days over a week. The variable of interest - fruit (cup) - values for the 2 24-hour periods were added to ascertain the total amount consumed at the specific data collection time periods.

Data from Baseline (T1) was compared to that collected at T2 for each participant and averaged for an aggregate score. Positive numbers represent an increase in fruit consumed, negative numbers represent a decrease in fruit consumed.

Only participants who completed 2 days worth of dietary data were included in this analysis.

Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
Percentage of Change in Dietary Intake Behaviors - Vegetable (Cup)
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)

Assessed using the National Cancer Institute Automated Self-Administered 24-hour Recall (ASA24). Participants completed 24-hour Dietary Recalls on two random days over a week. The variable of interest - vegetables (cup) - values for the 2 24-hour periods were added to ascertain the total amount consumed at the specific data collection time periods.

Data from Baseline (T1) was compared to that collected at T2 for each participant and averaged for an aggregate score. Positive numbers represent an increase in vegetables consumed, negative numbers represent a decrease in vegetables consumed.

Only participants who completed 2 days worth of dietary data were included in this analysis.

Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
Percentage of Change in Dietary Intake Behaviors - Added Sugars (Teaspoon or 4gm)
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)

Assessed using the National Cancer Institute Automated Self-Administered 24-hour Recall (ASA24). Participants completed 24-hour Dietary Recalls on two random days over a week. The variable of interest - added sugars teaspoon or 4 gm) - values for the 2 24-hour periods were added to ascertain the total amount consumed at the specific data collection time periods.

Data from Baseline (T1) was compared to that collected at T2 for each participant and averaged for an aggregate score. Positive numbers represent an increase in added sugars consumed, negative numbers represent a decrease in added sugars consumed.

Only participants who completed 2 days worth of dietary data were included in this analysis.

Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
Percentage of Change in Dietary Intake Behaviors - Caloric Intake (Kcal)
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)

Assessed using the National Cancer Institute Automated Self-Administered 24-hour Recall (ASA24). Participants completed 24-hour Dietary Recalls on two random days over a week. The variable of interest - calories (Kcal) - values for the 2 24-hour periods were added to ascertain the total amount consumed at the specific data collection time periods.

Data from Baseline (T1) was compared to that collected at T3 for each participant and averaged for an aggregate score. Positive numbers represent an increase in calories consumed, negative numbers represent a decrease in calories consumed.

Only participants who completed 2 days worth of dietary data were included in this analysis.

Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
Percentage of Change in Dietary Intake Behaviors - Fat Intake (gm)
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)

Assessed using the National Cancer Institute Automated Self-Administered 24-hour Recall (ASA24). Participants completed 24-hour Dietary Recalls on two random days over a week. The variable of interest - fat (gm) - values for the 2 24-hour periods were added to ascertain the total amount consumed at the specific data collection time periods.

Data from Baseline (T1) was compared to that collected at T3 for each participant and averaged for an aggregate score. Positive numbers represent an increase in fat consumed, negative numbers represent a decrease in fat consumed.

Only participants who completed 2 days worth of dietary data were included in this analysis.

Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
Percentage of Change in Dietary Intake Behaviors - Fruit Intake (Cups)
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)

Assessed using the National Cancer Institute Automated Self-Administered 24-hour Recall (ASA24). Participants completed 24-hour Dietary Recalls on two random days over a week. The variable of interest - fruit (cup) - values for the 2 24-hour periods were added to ascertain the total amount consumed at the specific data collection time periods.

Data from Baseline (T1) was compared to that collected at T3 for each participant and averaged for an aggregate score. Positive numbers represent an increase in fruit consumed, negative numbers represent a decrease in fruit consumed.

Only participants who completed 2 days worth of dietary data were included in this analysis.

Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
Percentage of Change in Dietary Intake Behaviors - Vegetable Intake (Cups)
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)

Assessed using the National Cancer Institute Automated Self-Administered 24-hour Recall (ASA24). Participants completed 24-hour Dietary Recalls on two random days over a week. The variable of interest - vegetable (cup) - values for the 2 24-hour periods were added to ascertain the total amount consumed at the specific data collection time periods.

Data from Baseline (T1) was compared to that collected at T3 for each participant and averaged for an aggregate score. Positive numbers represent an increase in vegetables consumed, negative numbers represent a decrease in vegetables consumed.

Only participants who completed 2 days worth of dietary data were included in this analysis.

Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
Percentage of Change in Dietary Intake Behaviors - Added Sugars Intake (gm)
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)

Assessed using the National Cancer Institute Automated Self-Administered 24-hour Recall (ASA24). Participants completed 24-hour Dietary Recalls on two random days over a week. The variable of interest - added sugars (teaspoon or 4 gm) - values for the 2 24-hour periods were added to ascertain the total amount consumed at the specific data collection time periods.

Data from Baseline (T1) was compared to that collected at T3 for each participant and averaged for an aggregate score. Positive numbers represent an increase in added sugars consumed, negative numbers represent a decrease in added sugars consumed.

Only participants who completed 2 days worth of dietary data were included in this analysis.

Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
Percentage of Change in Physical Activity - 7-Day Metabolic Equivalent of Task (MET)
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)

Assessed using Actigraph (GT3x), an objective measurement of physical activity. Investigators distributed the Actigraph in person participants' home (T2 and T3) to wear at the wrist at least seven consecutive days (≥ 10 hours/per day).

The variable of interest - 7-day MET - values for the period was added to ascertain the total amount at the specific data collection time periods.

Data from Baseline (T1) was compared to that collected at T2 for each participant and averaged for an aggregate score. Positive numbers represent an increase in physical activity negative numbers represent a decrease in physical.

Only participants who completed the minimum requirement for reporting [wear at the wrist at least seven consecutive days (≥ 10 hours/per day)] were included in the analysis.

Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
Percentage of Change in Physical Activity - 7-Day Metabolic Equivalent of Task (MET)
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)

Assessed using Actigraph (GT3x), an objective measurement of physical activity. Investigators distributed the Actigraph in person participants' home (T2 and T3) to wear at the wrist at least seven consecutive days (≥ 10 hours/per day).

The variable of interest - 7-day MET - values for the period was added to ascertain the total amount at the specific data collection time periods.

Data from Baseline (T1) was compared to that collected at T3 for each participant and averaged for an aggregate score. Positive numbers represent an increase in physical activity negative numbers represent a decrease in physical.

Only participants who completed the minimum requirement for reporting [wear at the wr

Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
Change in Emotion Regulation
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
The Emotion Regulation Questionnaire (10 items) was used to measure emotional control. The questionnaire asked participants to report the use of emotional regulatory process using a 7-point scale ranging from 1 (strongly disagree) to 7 (strongly agree). After revise coding 4 items, we summed responses of 10 items to create an emotional control score (ranged from 10 to 70). Higher scores indicated better emotional control.
Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
Change in Emotion Regulation
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
The Emotion Regulation Questionnaire (10 items) was used to measure emotional control. The questionnaire asked participants to report the use of emotional regulatory process using a 7-point scale ranging from 1 (strongly disagree) to 7 (strongly agree). After revise coding 4 items, we summed responses of 10 items to create an emotional control score (ranged from 10 to 70). Higher scores indicated better emotional control.
Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
Change in Executive Function - Behavior Regulation
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
The Behavior Rating Inventory of Executive Function-Adults (75 items) was used to measure executive function. This survey asked participants to rate self-regulation behaviors in the everyday environment using a 3-point Likert scale ranging from 0 (never) to 2 (often). This survey covers 2 main domains: behavior regulation (30 items) and metacognition (45 items). We summed responses to the 30 behavior regulation items to create a behavior regulation score. Behavior regulation scores range from 0-60. We used the same approach to create a composite score for metacognition. Higher scores indicated worse behavior regulation or metacognition. The scores from T1 were compared to scores for T2 to evaluate the effect of the intervention.
Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
Change in Executive Function - Behavioral Regulation
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
The Behavior Rating Inventory of Executive Function-Adults (75 items) was used to measure executive function. This survey asked participants to rate self-regulation behaviors in the everyday environment using a 3-point Likert scale ranging from 0 (never) to 2 (often). This survey covers 2 main domains: behavior regulation (30 items) and metacognition (45 items). We summed responses to the 30 behavior regulation items to create a behavior regulation score. Behavior regulation scores range from 0-60. We used the same approach to create a composite score for metacognition. Higher scores indicated worse behavior regulation or metacognition. The scores from T1 were compared to scores for T3 to evaluate the effect of the intervention.
Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
Change in Executive Function - Metacognition
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
The Behavior Rating Inventory of Executive Function-Adults (75 items) was used to measure executive function [31]. This survey asked participants to rate self-regulation behaviors in the everyday environment using a 3-point scale ranging from 0 (never) to 2 (often). This survey covers 2 main domains: behavior regulation (30 items) and metacognition (45 items). We summed responses to the 30 behavior regulation items to create a behavior regulation score. We used the same approach to create a composite score for metacognition. Metacognition scores range from 0-90. Higher scores indicated worse metacognition. The scores from T1 were compared to scores from T2 to evaluate the effect of the intervention.
Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2)
Change in Executive Function - Metacognition
Time Frame: Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)
The Behavior Rating Inventory of Executive Function-Adults (75 items) was used to measure executive function [31]. This survey asked participants to rate self-regulation behaviors in the everyday environment using a 3-point scale ranging from 0 (never) to 2 (often). This survey covers 2 main domains: behavior regulation (30 items) and metacognition (45 items). We summed responses to the 30 behavior regulation items to create a behavior regulation score. We used the same approach to create a composite score for metacognition. Metacognition scores range from 0-90. Higher scores indicated worse metacognition. The scores from T1 were compared to scores from T3 to evaluate the effect of the intervention.
Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Mei-Wei Chang, PhD, Ohio State University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2021

Primary Completion (Actual)

January 30, 2023

Study Completion (Actual)

December 30, 2023

Study Registration Dates

First Submitted

October 19, 2020

First Submitted That Met QC Criteria

November 4, 2020

First Posted (Actual)

November 10, 2020

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

November 14, 2024

Last Verified

November 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Goal-Oriented Episodic Future Thinking

Subscribe